Yahoo
LSE - Delayed Quote GBp

ECO Animal Health Group plc (EAH.L)

95.50 0.00 (0.00%)
At close: October 30 at 3:44:24 PM GMT
Chart Range Bar
Loading chart for EAH.L
  • Previous Close 95.50
  • Open 97.00
  • Bid 94.00 x --
  • Ask 97.00 x --
  • Day's Range 94.15 - 97.00
  • 52 Week Range 80.01 - 116.90
  • Volume 76,804
  • Avg. Volume 148,066
  • Market Cap (intraday) 63.725M
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) 31.83
  • EPS (TTM) 0.03
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Sep 23, 2021
  • 1y Target Est 202.00

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

ecoanimalhealth.com

213

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

EAH.L
8.61%
FTSE 100 (^FTSE)
8.04%

1-Year Return

EAH.L
15.06%
FTSE 100 (^FTSE)
9.94%

3-Year Return

EAH.L
11.98%
FTSE 100 (^FTSE)
46.43%

5-Year Return

EAH.L
64.30%
FTSE 100 (^FTSE)
48.25%

Analyst Insights

View More

Analyst Price Targets

165.00
202.00 Average
95.50 Current
273.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.50%

  • Return on Assets (ttm)

    2.99%

  • Return on Equity (ttm)

    3.84%

  • Revenue (ttm)

    87.53M

  • Net Income Avi to Common (ttm)

    2.19M

  • Diluted EPS (ttm)

    0.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.43M

  • Total Debt/Equity (mrq)

    5.16%

  • Levered Free Cash Flow (ttm)

    5.34M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: